Rationale: The prognostic value of cardiopulmonary exercise testing (CPET) for survival in cystic fibrosis (CF) in the context of current clinical management, when controlling for other known prognostic factors, is unclear.
In patients with cystic fibrosis (CF), an increased risk of death has been associated with poor values of FEV 1 ; short stature; low body mass index (BMI); pancreatic insufficiency; CF-related diabetes (CFRD); and chronic infection with specific pathogens, such as Pseudomonas aeruginosa, Burkholderia cepacia, or Mycobacteria other than tuberculosis (1) (2) (3) .
Several studies have shown that cardiopulmonary exercise testing (CPET) can also provide prognostic information in CF with respect to mortality (4) (5) (6) (7) (8) (9) . _ VO 2 peak and change in _ VO 2 peak over time, peak work rate (Wpeak), the respiratory equivalent for oxygen ( _ VE divided by _ VO 2 ) at peak exercise ( _ VE/ _ VO 2 peak), and the breathing reserve index at the ventilatory threshold ( _ VE divided by the estimated maximal voluntary ventilation [MVV] ) during an incremental cycling test were identified as predictors of death (4) (5) (6) (7) (8) (9) .
The analysis of prognostic factors in CF remains a challenge because of its multifactorial complexity. Previous studies investigating the association between CPET and survival in CF usually considered only a selection of established predictors of mortality and/or lung transplantation (LTx) (e.g., FEV 1 and BMI) for adjustment in their statistical models. The decision for the choice of covariates for the final multivariable models was mostly based on significant univariate associations of single CPET parameters. This may, however, overestimate the predictive value of CPET for CF survival because numerous other factors are associated with the outcome.
Another possibility of identifying high-risk patients is to use cluster analysis, such as Ward hierarchical clustering, an unbiased, data-driven approach to define clinical/physiologic phenotypes (10) . Such an analysis may help to characterize subgroups with respect to clinical characteristics that could be useful for further investigations and/or intervention strategies.
The primary objective of the present project was to determine the prognostic value of _ VO 2 peak (primary analysis) and other CPET-derived parameters after rigorous adjustment of a significant number of established predictors of mortality in CF that are usually assessed during routine clinical assessments in a large multicenter cohort. We further wanted to evaluate whether the importance of predictors changes over time using prespecified time periods (i.e., 5, 8, and 10 yr after CPET) to allow comparisons with previous studies (4) (5) (6) (7) . An additional objective in relation to the study question was to examine whether CPET-derived variables were important to define phenotypes that are associated with LTx and mortality.
Methods Study Design and Subjects
For this retrospective study, we analyzed data of patients with CF aged greater than or equal to 10 years who had a full CPET meeting prespecified criteria between January 1, 2000, and December 31, 2007, and for whom follow-up information on survival or LTx was available 5 years after CPET. Patients who left their respective CF center earlier than 5 years after CPET without information on LTx or subsequent survival available were not included in the analysis. Ethical approval was obtained from all respective ethical research committees, if required (see online supplement).
Cardiopulmonary Exercise Testing
For each patient, only one CPET was included in the analysis. In patients who had multiple tests during the study period, the first valid test was selected. An overview on equipment and exercise protocols used to perform the CPET (see Table E1 in the online supplement) and criteria for a maximal effort are available in the online supplement.
Statistical Analysis
Data are presented as number (%), mean 6 SD (ranges), and hazard ratios (HRs) with 95% confidence intervals (CI). Data from lung function testing and CPET were converted to % predicted (11) (12) (13) . We calculated BMI z-scores for children and adolescents (14) and adults (15) . The primary composite endpoint for survival was LTx and/or death.
The relationship of _ VO 2 peak (and Wpeak) with LTx and/or death was visualized by plotting survival (KaplanMeier curves) of three groups using cutoffs used by Nixon and colleagues (4) for Cox proportional hazards regression. The Cox proportional hazards assumption was verified graphically (log-log plot) and tested using Schoenfeld residuals and there was no indication of a violation of this assumption.
First, the association between potential predictors and the compound outcome (death and/or LTx) was studied in a univariate analysis using Cox proportional random effects hazards models adjusted for clustering on the center level. In a second step, we assessed the prognostic value of CPET-derived parameters ( _ VO 2 peak, Wpeak, _ VEpeak/MVVpred, _ VE/ _ VO 2 peak, _ VE/ _ VCO 2 peak, oxygen saturation at peak exercise as measured by pulse oximetry (Sp O 2 peak), and the Δ _ VE/Δ _ VCO 2 slope) in addition to known predictors of survival in CF in multivariable models. Cox proportional hazards regression models were performed including FEV 1 (% predicted), BMI (z-score), age at CPET, sex, and the binary coded variables (yes/no) chronic P. aeruginosa colonization and CFRD. Exocrine pancreatic insufficiency was a predefined covariate to be considered for the statistical model. However, because none of the cases (LTx/death) in our dataset was pancreatic sufficient, we were not able to compute effect estimates and 95% CIs. Consequently, pancreatic insufficiency was not Table  E2 ) and there was no significant difference with respect to the distribution of mutations between cases and control subjects for patients in whom the genotype was available, we did not consider CFTR genotype as a covariate in the final models.
The final Cox model analysis was restricted to 10-year follow-up data because of low numbers of cases (n = 8) from only three study centers with more than 10-year follow-up data. In addition, we evaluated predictors of survival for different time periods (e.g., 5, 8, and 10 yr) using Cox models with time-varying covariates.
In addition, an unsupervised, datadriven approach was used to explore the relevance of CPET-derived parameters to predict death/LTx in patients with CF. Physiologic and clinical parameters were used as input to define clusters by Ward hierarchical clustering (10) . The relevance of each clustering parameter was investigated using a Forest plot. Based on the results of the Forest plot, the parameters for clustering were selected and finally, the association of the identified clusters with LTx and/or death using Kaplan-Meier curves was studied.
All analyses were performed using Stata statistical software version 12 (StataCorp) and R version 3.0.2 (http://www.R-project. org). A probability for a type I error P less than 0.05 was considered statistically significant.
Results
Data from 10 CF centers from Australia, Europe, and North America were included in this study. A flow chart is shown in Figure 1 . A total of 433 of 510 CPETs fulfilled at least one of the four predefined criteria for a maximal effort (i.e., plateauing of _ VO 2 , or respiratory exchange ratio, heart rate, or _ VE exceeding the previously mentioned thresholds) and were, thus, used for the final analysis. Patients with a nonmaximal effort during CPET (n = 77) were younger (13.7 6 3.5 yr; P , 0.001), had comparable FEV 1 (74.0 6 21.7% predicted; P = 0.868), and showed a trend of lower _ VO 2 peak (77.3 6 18.6% predicted; P = 0.066) compared with the final study population. Of 77 excluded patients, eight (10%) died or had an LTx during the entire follow-up period. We noticed differences in deaths/LTx among study centers (see Table E3 ) and consequently adjusted all models for study center. Table 1 summarizes patients' characteristics. Detailed information on patient's clinical characteristics and CPET outcomes separated by study center are shown in Tables E3 and E4 .
Survival rates in our study population were 93.1%, 84.7%, and 69.3% after 5, 8, and 10 years, respectively. Survival probabilities for different _ VO 2 peak categories are shown in the Kaplan-Meier curve ( Figure 2 ). A figure with Wpeak categories is shown in the online supplement (see Figure E1 ).
Results of Cox Proportional Hazards Models (Univariate and Adjusted Analyses)
In univariable random effects models with study center adjustment, the CPET-derived information on _ VO 2 peak, Wpeak, _ VE/ _ VO 2 peak, _ VE/ _ VCO 2 peak, _ VEpeak/ MVVpred, Sp O 2 peak, and the Δ _ VE/Δ _ VCO 2 slope was each a significant predictor of death or LTx (see Table E5 ). Furthermore, in the complete data set, all CPET-derived parameters were significant in the univariable models without study center adjustment (crude estimates are shown in Table E6 ). A low FEV 1 and BMI, as well as chronic P. aeruginosa colonization, were also related to death or LTx (see Tables E5  and E6). A subanalysis restricted to patients with advanced lung disease (FEV 1 <40% predicted) identified age at CPET, _ VO 2 peak, Wpeak, _ VE/ _ VO 2 peak, and _ VE/ _ VCO 2 peak as significant predictors of death or LTx (see Table E7 ). Comparable results for CPET variables were found in non-centeradjusted analyses (see Table E8 ).
In an exploratory analysis aiming to assess the short-term prognostic value of CPET-derived parameters and restricted to 2-year follow-up data (n = 433 patients with 11 death/LTx cases), _ VO 2 peak, Wpeak, _ VE/ _ VO 2 peak, _ VE/ _ VCO 2 peak, _ VEpeak/MVVpred, and Sp O 2 peak as well as FEV 1 and BMI were each significantly associated with death or LTx (see Tables E9  and E10) . Results from these short-term models were similar to complete dataset models (see Tables E5 and E6 ), except for a significant effect of chronic P. aeruginosa colonization on death or LTx (see Tables E9  and E10 ).
When adjusting the models for sex, age at CPET, FEV 1 (% predicted), BMI (z-score), chronic P. aeruginosa colonization, and CFRD the variables _ VO 2 peak, Wpeak,
Excluded Excluded
Included in statistical analysis N=433
Subjects that met eligibility criteria N=510
Total study sample N=570
• N = 40 Lost to follow-up.
• N = 18 Missing information regarding primary endpoint (death/lung transplantation).
• N = 2 Missing CPET.
• N = 77 No valid maximal CPET according to pre-specified criteria. ORIGINAL ARTICLE _ VE/ _ VO 2 peak, and _ VE/ _ VCO 2 peak remained significant predictors of death or LTx ( Table 2) . Characteristics of patients within the three _ VO 2 peak categories are shown in Table E11 . Patients in the highest and middle _ VO 2 peak groups (>82% predicted and 59-81% predicted, respectively) had a 72% (HR, 0.278; 95% CI, 0.088-0.882; P = 0.030) and 49% (HR, 0.507; 95% CI, 0.259-0.993; P = 0.048) lower risk of dying or to receive a lung transplant within the next 10 years compared with patients with a _ VO 2 peak of less than or equal to 58% of the predicted value. In the model with Wpeak, patients in the highest Wpeak group (>92% predicted) showed a trend for lower chance for death or LTx (HR, 0.417; 95% CI, 0.155-1.123; P = 0.084).
In the Cox models including timevarying covariates, no effects were observed for different predictors of survival for different time periods (e.g., 5, 8, and 10 yr, data not shown).
Results of Ward Hierarchical Clustering
All CPET parameters and FEV 1 had a high variable importance to define clusters, as indicated by the Forest plot ( Figure 3) . However, the binary coded variables (sex, chronic P. aeruginosa infection, pancreatic insufficiency, and CFRD) were less important. Based on the forest plot, the eight continuous variables (FEV 1 , BMI, Wpeak, age at CPET, _ VO 2 peak, _ VEpeak/MVVpred, _ VE/ _ VO 2 peak, and _ VE/ _ VCO 2 peak) were introduced into the principal component analysis, and five orthogonal factors explained more than 95% of variance (see Table E12 ). We identified four clusters ( Table 3 ). The prevalence of the primary outcome death/LTx during the study period was 2% in cluster 1, 15% in cluster 2, 67% in cluster 3, and 39% in cluster 4. Cluster 3 was considered a high-risk cluster because the prevalence of the primary outcome death/LTx during the 10-year study period (63%) was highest compared with the other three clusters (Table 3, Figure 4 ). This cluster was further characterized by a poor performance for all CPET parameters, a high prevalence of P. aeruginosa colonization, low BMI z-score, and low FEV 1 and FVC values (see Figure E2) .
We further identified a group of older patients (n = 33, cluster 4) with poor lung function, high prevalence of chronic P. aeruginosa colonization and CFRD, but only a modest reduction in BMI and (almost) preserved exercise capacity (Table 3) . This group of patients had better survival compared with patients belonging to cluster 3.
Discussion
Previous studies of the prognostic value of CPET in CF have been limited by small sample sizes that could not control for many well-recognized confounding prognostic factors (4-9). The present study evaluated a large international sample of patients to examine the utility of CPET parameters in predicting survival over the subsequent 10 years. The study confirms the importance of _ VO 2 peak and Wpeak as key predictors of survival, but also identifies other CPET measures ( _ VE/ _ VO 2 peak and _ VE/ _ VCO 2 peak) that may be of great prognostic significance. The use of cluster analysis further suggests at-risk phenotypes in whom early recognition, nutritional counseling, and exercise intervention could be most beneficial. This is the largest study investigating the prognostic value of CPET-derived Definition of abbreviations: BMI = body mass index; CFRD = cystic fibrosis-related diabetes; CFTR = cystic fibrosis transmembrane conductance regulator; LTx = lung transplantation; _ VO 2 peak = peak oxygen uptake; Wpeak = peak work rate. N = 433. Data are mean 6 SD (ranges) or number (% of the study sample). *Information on both CFTR mutations were available for 337 patients. . Figure 2 . Kaplan-Meier survival curve for three different _ VO 2 peak groups. _ VO 2 peak = peak oxygen uptake. Data are hazard ratios (95% confidence interval) and probability of a type I error.
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parameters in a heterogeneous sample of both pediatric and adult patients with CF from Australia, Europe, and North America and a follow-up period of up to 14 years. Previous studies investigating the prognostic value of CPET-derived variables in patients with CF were all single-center studies, performed in either children (6, 7, 9) and both children and adults (4, 5, 8) with much fewer cases in some studies (9-61 deaths/lung transplants) compared with our study, and also shorter follow-up periods ranging from less than 1 year to 8 years (4-9). We extend the current knowledge on the predictive value of CPET-derived parameters in addition to established prognostic markers in a large and international cohort and identified _ VE/ _ VO 2 and _ VE/ _ VCO 2 as important prognostic factors.
In our study, patients with the highest _ VO 2 peak (>82% predicted) had a 72% (HR, 0.278; 95% CI, 0.088-0.882) and 49% (HR, 0.507; 95% CI, 0.259-0.993) lower risk of dying or receiving a lung transplant in the following 10 years compared with patients in the middle (59-81% predicted) and lowest _ VO 2 peak category (<58% predicted), respectively. These findings are in line with a landmark single-center study on 109 patients with CF (age 7-35 yr; FEV 1 59% predicted [range, 24-95%]) demonstrating for the first time that a high aerobic exercise capacity is associated with lower risk of dying over 8 years in CF (4). We confirm the concept and extend these data in a large and international sample of pediatric and adult patients with CF treated in the modern era. Indeed, in the study by Nixon and colleagues (4) more than 20 years ago, 8-year survival rates were much lower compared with our study population (56% vs. 85% survival rate). Although survival rates in CF have substantially improved over the last decades (16, 17) , we also observed an overall higher _ VO 2 peak in our study population compared with the Nixon study population (82% predicted [range, vs. 70% predicted [range, 21-132]) using the same _ VO 2 peak prediction equations (4) . Our data clearly confirm that a well-preserved fitness remains important for survival in CF and possibly reflects improvements in treatment and the change in practice with regard to the acceptance of exercise as a key element in CF treatment and a stronger focus on exercise counseling.
In multivariable models, we identified _ VO 2 peak, Wpeak, and _ VE/ _ VO 2 and _ VE/ _ VCO 2 at peak exercise as predictors of death/LTx even after rigorous adjustment for established predictors of death in CF (1-3). In our study, age at CPET and FEV 1 were significant predictors of death/LTx in all fully adjusted models. Lung disease severity, assessed with FEV 1 , is well known to be a strong predictor of survival in CF (18) and whether FEV 1 or _ VO 2 peak is a stronger predictor of survival in CF is controversial (4-6). Most (5-8), but not all, studies (4) evaluating the prognostic value of CPETderived parameters showed strong associations of FEV 1 with mortality in multivariable models. In our study, FEV 1 explained the greatest variance of subsequent death/LTx in the adjusted Cox models and FEV 1 was the variable with the highest importance for phenotypic clustering (Figure 3) . Interestingly, all CPET-related variables (except Wpeak) had a higher importance for the outcome death/LTx than other established predictors of survival in CF. This finding supports the conclusion that CPETderived variables are important prognostic factors in CF.
Beside _ VO 2 peak and Wpeak as known predictors of mortality (4-6, 9), _ VE/ _ VO 2 and _ VE/ _ VCO 2 at peak exercise were also associated with death/LTx in our patient population. The _ VE/ _ VO 2 peak (a marker of ventilatory efficiency at peak exercise) was previously identified as stronger predictor of survival than _ VO 2 peak in univariate analyses of adult patient data (5). In another study using multivariable analysis in a cohort of 127 children with CF aged 11-14 years (7), the equation to predict a higher risk of mortality included _ VE/ _ VO 2 peak, BMI, and FEV 1 (%). These data are supported by our cluster analysis (see variable importance plot in Figure 3 ), indicating that _ VE/ _ VO 2 peak has a greater importance for phenotype clustering than _ VO 2 peak. The highest values for _ VE/ _ VO 2 peak and _ VE/ _ VO 2 peak were observed in the high-risk group (cluster 3 in Table 3 ), which was also the group with the lowest FVC that is suggestive of a higher dead space ventilation and reduced breathing reserve (i.e., _ VEpeak/MVVpred was highest in cluster 3). Interestingly, clusters 3 and 4 were both characterized by severe lung function impairment, but patients in cluster 3 were younger, had worse nutritional status (BMI), and substantially lower exercise capacity, whereas CFTR genotype showed no obvious differences compared with the other clusters (e.g., proportion of patients with severe CFTR mutations). Thus, we can only speculate on underlying reasons, such as lower daily physical activity levels, but these data were not available. Nevertheless, this cluster of patients may especially benefit from regular monitoring of exercise capacity and appropriate exercise counseling to improve nutritional status, one of the key predictors of aerobic exercise capacity in CF (19) .
This study has limitations. We included data from 10 CF centers from different countries with likely heterogeneous diagnostic and treatment regimens possibly introducing bias. For these reasons, all statistical models were adjusted for study center as random intercept. The models incorporate the fact that measurements from the same center are not independent, but more similar to each other by assigning an individual intercept for each center. This way, CF care centers with systematically biased values (e.g., clearly above or below the average) should not substantially change the overall results.
A priori, we included data from patients for whom follow-up information on survival and LTx was available greater than or equal to 5 years after CPET. Thus, patients who left their respective center shortly after the CPET were excluded already when the data were collected. This approach might have introduced some bias. It is possible that we excluded more healthy and active patients who left their hometown for education or work. However, it is also possible that we excluded patients who were not doing well and were unhappy with their center care. By excluding the few cases on whom follow-up data were not available for at least 5 years (n = 40), the number of cases available for analysis was somewhat reduced. However, because clear information on survival or death/LTx was available on all cases for at least 5 years, the analyses are more sound.
Because of a large number of missing data on both CFTR mutations (22%) and unequal distribution among cases and survivors, we were not able to adjust the models for CFTR genotype, a well-known predictor of survival in CF (20, 21) .
The data used for this study were gathered retrospectively. Thus, we had to limit the variables used as predictors of prognosis to those that were commonly assessed during the years 2000-2007. Because, for example, colonization with mycobacteria other than tuberculosis or Definition of abbreviations: BMI = body mass index; CFRD = cystic fibrosis-related diabetes; CFTR = cystic fibrosis transmembrane conductance regulator; CPET = cardiopulmonary exercise testing; LTx = lung transplantation; MVV = maximal voluntary ventilation; PA = chronic Pseudomonas aeruginosa infection; Sp O 2 peak = oxygen saturation at peak exercise; _ VEpeak/MVVpred = breathing reserve index (MVV was calculated as FEV 1 3 35); _ VE/ _ VCO 2 peak = ventilatory equivalent for carbon dioxide; _ VE/ _ VO 2 peak = ventilatory equivalent for oxygen; _ VO 2 peak = peak oxygen consumption; Wpeak = peak work rate. Data are mean 6 SD or number (%). Data for Δ _ VE/Δ _ VCO 2 slope were only available for a subset of patients (cluster 1 = 119, cluster 2 = 56, cluster 3 = 18, and cluster 4 = 21). Differences among clusters were analyzed using chi-square tests for categorical variables and Kruskal-Wallis, as appropriate. The Bonferroni-corrected significance level for these tests was 0.008 (overall significance level [0.05] divided by number of tests, which was six because we compared four clusters). If the test passed the significance level, this is indicated by a footnote as shown below. *Difference between cluster 1 and 4. † Difference between cluster 2 and 3. ‡ Difference between cluster 2 and 4. x Difference between cluster 3 and 4. jj Difference between cluster 1 and 2. ¶ Difference between cluster 1 and 3. **Differences between clusters based on chi-square statistics (P = 0.039). If chi-square statistics are calculated for patients with known genotype by excluding patients with at least one "unknown; nonavailable" CFTR allele, no difference in genotype is observed between the groups (P = 0.338).
B. cepacia complex was not vigorously assessed at that time, such information could not be included in the models.
It is important to note that transplant predictions (i.e., timing for referral for LTx) are usually based on 2-year mortality data in CF (22) . Our study was not designed to assess short-term outcomes and established predictors of mortality for short-term prediction of mortality, such as 6-minutewalk test distance, and infection with mycobacteria or B. cepacia complex (22) were not validly available in our retrospective data collection. In an exploratory analysis restricted to 2-year follow-up data (n = 433), which includes only a small number of death/LTx cases (n = 11), all CPET parameters except the Δ _ VE/Δ _ VCO 2 slope were significantly associated with death/LTx. However, these findings must be interpreted with caution and the short-term prognostic value of CPET-derived variables should be investigated in a well-designed prospective study including known predictors of referral for LTx (22) .
Finally, our data were collected before initiation of CFTR modulator therapies. Because these drugs may impact on lung function and overall survival, the predictors should be reevaluated in the context of highly effective CFTR modulators that may become available to most patients with CF in the upcoming years.
Because aerobic fitness and ventilatory efficiency measured during CPET are related to prognosis, it is important to show whether improvements in these measures would translate into increased survival. Several randomized controlled trials have shown that exercise capacity can be increased in CF by exercise conditioning programs (23) . However, no conditioning studies with survival/mortality being the primary outcome are available to date. Because information from exercise testing in CF is relevant to patient care in several aspects, such as detecting adverse reactions to exercise, understanding exercise limitations, guiding a conditioning program, or motivating people to engage in strenuous physical activities, an increasing number of centers are including formal exercise testing in their routine work-up of patients with CF. Including the information from these tests in patient registries might in the future show whether patients who get fitter will benefit with respect to longevity.
Conclusions
Data collected during CPET, such as _ VO 2 peak, Wpeak, _ VE/ _ VO 2 peak, and _ VE/ _ VCO 2 peak, provide prognostic information in addition to established predictors of death/LTx in CF. Cluster analysis revealed that CPET-derived measures were important for phenotyping. The phenotype with the highest risk for death/LTx identified by Ward hierarchical clustering is characterized by poor lung function, nutritional status, and exercise capacity and may thus especially benefit from regular monitoring of exercise capacity, nutritional counseling, and exercise intervention. n Author disclosures are available with the text of this article at www.atsjournals.org. Figure 4 . Variable importance plot generated by the unsupervised random forest algorithm from the 12 clinical and physiologic parameters used for clustering. Higher values corresponded to higher importance of the variable for clustering. BMI = body mass index; CFRD = cystic fibrosis-related diabetes; CPET = cardiopulmonary exercise testing; MVV = maximal voluntary ventilation; PA = chronic Pseudomonas aeruginosa infection; PI = pancreatic insufficiency; _ VEpeak/MVVpred = breathing reserve index (MVV was calculated as FEV 1 3 35); _ VE/ _ VCO 2 peak = ventilatory equivalent for carbon dioxide; _ VE/ _ VO 2 peak = ventilatory equivalent for oxygen; _ VO 2 peak = peak oxygen consumption; Wpeak = peak work rate.
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